Metabolic regulation of the immune system in health and diseases: mechanisms and interventions

T Hu, CH Liu, M Lei, Q Zeng, L Li, H Tang… - Signal Transduction and …, 2024 - nature.com
Metabolism, including glycolysis, oxidative phosphorylation, fatty acid oxidation, and other
metabolic pathways, impacts the phenotypes and functions of immune cells. The metabolic …

The B7: CD28 family and friends: Unraveling coinhibitory interactions

KP Burke, A Chaudhri, GJ Freeman, AH Sharpe - Immunity, 2024 - cell.com
Immune responses must be tightly regulated to ensure both optimal protective immunity and
tolerance. Costimulatory pathways within the B7: CD28 family provide essential signals for …

Interruption of the intratumor CD8+ T cell: Treg crosstalk improves the efficacy of PD-1 immunotherapy

SN Geels, A Moshensky, RS Sousa, C Murat… - Cancer Cell, 2024 - cell.com
PD-1 blockade unleashes potent antitumor activity in CD8+ T cells but can also promote
immunosuppressive T regulatory (Treg) cells, which may worsen the response to …

Tumour-associated macrophages: versatile players in the tumour microenvironment

ZZ Ji, MKK Chan, ASW Chan, KT Leung… - Frontiers in cell and …, 2023 - frontiersin.org
Tumour-Associated Macrophages (TAMs) are one of the pivotal components of the tumour
microenvironment. Their roles in the cancer immunity are complicated, both pro-tumour and …

Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells

X Meng, JA Layhadi, ST Keane, NJK Cartwright… - Asia Pacific …, 2023 - journals.lww.com
T and B cells are key components of the adaptive immune system. Through their immune
properties and their interactions with other immune cells and cytokines around them, they …

Beyond HMAs: Novel targets and therapeutic approaches

TM Getz, JP Bewersdorf, T Kewan, JM Stempel… - Seminars in …, 2024 - Elsevier
Myelodysplastic syndromes/neoplasms (MDS) constitute a heterogeneous group of clonal
hematopoietic disorders with extremely variable clinical features and outcomes …

[HTML][HTML] Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

AM Eshaq, TW Flanagan, AA Ba Abbad… - International Journal of …, 2024 - mdpi.com
Immunotherapy, particularly that based on blocking checkpoint proteins in many tumors,
including melanoma, Merkel cell carcinoma, non-small cell lung cancer (NSCLC), triple …

[HTML][HTML] A Bioinformatics Investigation of Hub Genes Involved in Treg Migration and Its Synergistic Effects, Using Immune Checkpoint Inhibitors for Immunotherapies

N Kim, S Na, J Pyo, J Jang, SM Lee, K Kim - International Journal of …, 2024 - mdpi.com
This study aimed to identify hub genes involved in regulatory T cell (Treg) function and
migration, offering insights into potential therapeutic targets for cancer immunotherapy. We …

[HTML][HTML] Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments

FN Hamza, KS Mohammad - Pharmaceuticals, 2024 - mdpi.com
Bone metastases are a prevalent complication in advanced cancers, particularly in breast,
prostate, and lung cancers, and are associated with severe skeletal-related events (SREs) …

Interruption of the Intratumor CD8: Treg Crosstalk Improves the Efficacy of PD-1 Immunotherapy

SN Geels, A Moshensky, RS Sousa, BL Walker… - bioRxiv, 2023 - biorxiv.org
SUMMARY PD-1 blockade unleashes the potent antitumor activity of CD8 cells but can also
promote immunosuppressive T regulatory (Treg) cells, which may worsen response to …